All post-baseline efficacy measurements taken 6 or more (≥6) days after the last dose of study medication were not included. Least-squares means, standard errors, confidence intervals, and p-values were from linear contrasts of an ANCOVA model with treatment group as a factor and baseline as a covariate. *Indicates statistical significance at 0.05 level. 1. n was the number of patients with values at both baseline and endpoint.
2. Baseline was defined as the measurement at Visit 2. If the Visit 2 measurement was missing, the last valid measurement prior to the first dose of randomized double-blind study medication was used. 3. Week 12 endpoint was defined as the Visit 6 (Week 12) measurement. If the Visit 6 (Week 12) measurement was missing, the last valid post-baseline measurement during the double-blind treatment period was carried forward as the endpoint measurement. ANCOVA = analysis of covariance; CI = confidence interval; LS = least squares; SD = standard deviation; SE = standard error; vs. = versus.
